Intron sequences involved in lariat formation during pre-mRNA splicing

Area of Science:

• Molecular Biology
• Genetics
• RNA Processing

Background:

• RNA splicing is a fundamental process in gene expression.
• Lariat formation is a key step in splicing, but its precise mechanism and location are not fully understood.
• Mutations affecting splicing, such as those in beta-thalassemia, can lead to genetic disorders.

Purpose of the Study:

• To identify and characterize the site of lariat formation during RNA splicing.
• To investigate the role of the branch-point sequence and 3' splice site elements in lariat formation.
• To examine how splicing mutations, specifically in beta-thalassemia, affect lariat formation.

Main Methods:

• In vitro splicing assays using RNA precursors from various organisms.
• Analysis of artificial introns lacking normal branch-point sequences.
• Examination of human beta-globin gene precursors with beta-thalassemia mutations.

Main Results:

• Lariat formation occurs at a unique, weakly conserved site 18-37 nucleotides upstream of the 3' splice site.
• In artificial introns, lariat formation occurs at a cryptic site approximately 23 nucleotides from the 3' splice site.
• In beta-thalassemia, lariat formation proceeds at the normal site despite altered splice site usage; however, deletions or mutations at the 3' splice site can block lariat formation.

Conclusions:

• The site of lariat formation is conserved and identifiable, located proximally to the 3' splice site.
• Specific sequences at the 3' splice site, including the polypyrimidine tract and AG dinucleotide, are critical for initiating 5' cleavage and subsequent lariat formation.
• Understanding lariat formation is vital for comprehending gene expression regulation and the impact of splicing defects in diseases like beta-thalassemia.